Two New Contracts with local NHS Trusts

One Health Group PLC
20 November 2023
 

 

 

 

20 November 2023

 

One Health Group PLC

("One Health" or "the Group")

 

Two New Contracts with local NHS Trusts

 

One Health Group PLC the independent provider of free high quality NHS care for patients referred for treatment in Orthopaedics, Spine, General Surgery and Gynaecology, is pleased to confirm it has extended its support of the NHS in working to reduce the national waiting list through two new contracts secured with local NHS trusts.

The Group is providing Barnsley Teaching Hospital with additional Orthopaedic capacity, and Derby & Burton NHS Foundation Trust with both Gynaecology and Orthopaedic capacity. These additional patients are transferred from the Trust's own internal waiting lists and are in addition to the patients One Health receives directly following a GP referral through 'patient choice'.

This activity is in addition to similar contracts secured in 2022/23 with Doncaster and Bassetlaw Teaching Hospitals (Orthopaedic & Spine) and Chesterfield Royal Hospital (Orthopaedic & Gynaecology). One Health has also increased capacity of its Orthopaedic support of Sheffield Teaching Hospital in the second half of this calendar year by 50%, with a view to this continuing to the end of March 2024."

 

Ends

 

For more information, please contact:

 

One Health Group plc                                                                                   via Square1 Consulting

 

Oberon Capital - AQSE Corporate Adviser and Broker                    +44 203 179 5300

Nick Lovering

Mike Seabrook

Adam Pollock

 

Square1 Consulting                                                                                        +44 207 929 5599

David Bick                                                                                                            +44 7831 381201

 

 

About One Health Group

 

One Health engages over 100 NHS Consultants who sub-specialise in the various surgeries offered by the Group, through a growing network of community-based outreach clinics and surgical operating locations. In the year to March 2023 One Health serviced almost 12,000 new patients, through over 29,000 consultations and performed 5,790 surgical procedures. One Health uses surgeons and anaesthetists that are mostly employed by the NHS, on a consultancy basis. It currently works with over 100 professionals across seven hospitals and over 30 CQC registered clinics.

One Health's activities are focused on areas where the patient needs are under-supplied by the local NHS service as well as locations where population density is relatively high, and the level of private medical insurance is relatively low. One Health has also sought to expand geographically from its head office in Sheffield, South Yorkshire into neighbouring counties, which meet the required criteria. Currently, the Group's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue in the year to 31 March 2023 was derived from 60 Clinical Commissioning Groups in addition to contracts directly with NHS hospitals to manage their internal waiting lists.

One Health's business model has focused to date on four main areas: being Spine, Orthopaedics, General Surgery and Gynaecology. The split of inpatient procedures in the year to 31 March 2023 was as follows: Orthopaedics 44% Spine 27% General Surgery 22% Gynaecology 7%.

Orthopaedics and Spine are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopedics, the most common surgeries performed by One Health are knee and hip replacements.

*(https://www.onehealth.co.uk/investors)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100